Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Form 3 Q/C TECHNOLOGIES, INC. For: Sep 01 Filed by: Bernstein Bruce
-
Anheuser-Busch InBev (BUD) PT Raised to $92 at Bernstein SocGen Group
-
Pernod Ricard SA (RI:FP) (PDRDY) PT Lowered to EUR129 at Bernstein SocGen Group
-
Bernstein Reiterates Outperform Rating on McCormick & Company (MKC)
-
Dollar Tree (DLTR) PT Lowered to $100 at Bernstein SocGen Group
-
RTX Corp. (RTX) PT Raised to $181 at Bernstein SocGen Group
-
TKO Group Holdings (TKO) PT Raised at Bernstein on Contracted Growth & Sponsorship Upside'
-
Johnson & Johnson (JNJ) PT Raised to $193 at Bernstein SocGen Group
-
Bernstein SocGen Group Starts Klarna (KLAR) at Market Perform
-
Bernstein SocGen Group Starts Figure Technology (FIGR) at Outperform
-
Saint-Gobain capital markets day- Bernstein weighs in on what to expect
-
European Food/HPC stocks: Q3 earnings preview
-
Applied Materials falls after highlighting revenue hit from new BIS rule
-
Bernstein's China's Next Winners: 'The Picks and Shovels Playbook in ADAS Adoption'
-
Bernstein: Positive VESALIUS-CV Data Is 'Great News for Amgen (AMGN)'
-
Bernstein Reiterates Outperform Rating on Applied Materials (AMAT)
-
Bernstein Reiterates Market Perform Rating on AGCO Corporation (AGCO)
-
This European stock is Bernstein's Best Idea for Q4 2025
-
Elevate Your Escape: Updates on The Palm Beaches' Newest Hotels, Dining, Events & Attractions
-
Cascale Present at Worldly Customer Forum, ReThink Hong Kong
-
AB to Report Third Quarter 2025 Results on October 23, 2025
-
XML Financial Group Named to Forbes 2025 Top RIA Firms List
-
Is there risk of a momentum unwind? Bernstein answers
-
Bernstein on The Future of Broadband: 'Transitioning to a New Oligopolistic Equilibrium'
-
Bernstein: 'More Volatility Remains in Store for Intel (INTC) Shares'
-
Bernstein Reiterates Market Perform Rating on ConAgra (CAG)
-
Chipotle Mexican Grill (CMG) PT Lowered as Bernstein Predicts 3Q25 Miss
-
Bernstein Reiterates Underperform Rating on Deckers Outdoor (DECK)
-
Bernstein SocGen Group Starts Rightmove Plc. (RMV:LN) (RTMVY) at Outperform
-
Epilepsy Foundation of America Welcomes Four New Members to National Board of Directors
-
Valor PayTech Announces Strategic Investment from Lovell Minnick Partners to Accelerate Growth
-
Peloton shares jump after AI-driven overhaul
-
Bernstein on Thermo Fisher Scientific (TMO): 'Is Now the Time To Invest?... Buy the Strength'
-
Bernstein Calls Boston Scientific (BSX) a 'Great Stock Story'
-
Lamb Weston (LW) PT Raised to $65 at Bernstein, as 'Management Rebounds on Execution'
-
Bernstein on Nike (NKE): 'The Momentum Builds...'
-
Bernstein Reiterates Market Perform Rating on Carnival Corporation (CCL)
-
Bernstein SocGen Group Reiterates Outperform Rating on Chico's, Inc. (CHS)
-
Summa Health and HATCo Finalize Transaction, Launch Vision to Transform Healthcare in Akron and Beyond
-
China’s electrification push keeps this stock as a top pick: Bernstein
-
US Pfizer deal powers health stocks as drugmakers court Trump
-
Bernstein SocGen Group Starts Borouge PLC (BOROUGE:UH) at Market Perform
-
Novartis wins FDA approval for oral chronic urticaria treatment
-
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
-
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
-
US drugmakers rise after Trump announces Pfizer price cuts
-
Generational Group Advises Commercial Driver Services, Inc. in its Sale to TransTech, Inc.
-
Bernstein sees 'a strong buying opportunity' in this U.S. medical stock
-
Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
-
Bernstein: 'Should Netflix (NFLX) Acquire WBD?'
